# Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma

> **NCT01489410** · NA · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Drug-Eluting Beads (DEB) with Doxorubicin
- **DRUG:** Lipiodol Ethanol Mixture

## Key facts

- **NCT ID:** NCT01489410
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient staff
- **Last updated:** 2017-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489410, "Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01489410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
